Moreover, we noted that patients who experienced “new neoplasm event post initial therapy” in head and neck squamous cell carcinoma (HNSC), colorectal cancer, and tenosynovial giant cell tumor had elevated SOX1 expression in their original tumors (Supplementary Fig. S2C, Supplementary Table S1). Here, SOX1 is linked to tenosynovial giant cell tumor.